Wanbangde Pharmaceutical Holding Group (002082.SZ) Earnings Analysis

Wanbangde Pharmaceutical Holding Group (002082.SZ) has no confirmed upcoming earnings date. Trailing P/E -329.89.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002082.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 002082.SZ. This page updates as the calendar is published.

002082.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-12-31-0.1776 CNYn/an/an/a
2025-09-29-0.01471 CNYn/an/an/a
2025-06-30-0.00285 CNYn/an/an/a
2025-04-280.01591 CNYn/an/an/a
2025-03-310.0249 CNYn/an/an/a
2024-08-280.01433 CNYn/an/an/a

002082.SZ valuation and analyst view

Trailing P/E-329.89
Trailing EPS-0.18334 CNY
Price / book2.07
Dividend yield0.00%
Market cap5.84B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Wanbangde Pharmaceutical Holding Group (002082.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 002082.SZ. This page updates as the calendar is published.

Did 002082.SZ beat earnings last quarter?

Consensus estimate data was not available for 002082.SZ's 2025-12-31 report.

What is 002082.SZ's current P/E ratio and EPS?

002082.SZ trades at a trailing P/E of -329.89 on trailing EPS of -0.18333911388402507 CNY.

What do analysts rate 002082.SZ?

002082.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.